Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1977-08-18
1981-04-21
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548154, C07D27760
Patent
active
042633117
ABSTRACT:
The compounds are 5,6-phenyl-2,3-dihydroimidazo[2,1-b]thiazoles which have antiarthritic activity. A preferred compound is 5,6-bis(p-anisyl)-2,3-dihydroimidazo[2,1-b]thiazole.
REFERENCES:
patent: 2969369 (1961-01-01), Krimmel
patent: 3267112 (1966-08-01), Iwai
patent: 3274209 (1966-09-01), Raeymaekeus
patent: 3455924 (1969-07-01), Lednicer
patent: 3732215 (1973-05-01), Hawgwitz
patent: 3895021 (1975-07-01), Weinstock
patent: 3932395 (1976-01-01), Hideg
patent: 4059588 (1977-11-01), Baklien
patent: 4110460 (1978-08-01), Baetz
Mazur, A. I. et al., Chemical Abstracts, 72:12645P (1970), Abstract from Khim.-Favm. Zh. 3(8) 11-15 (1969).
Burger, A., "Medincinal Chemistry", 2nd ed., Interscience Publishers, Ltd., London, 1963, p. 42.
Foggio Richard D.
Keps Joan S.
Lourie Alan D.
Rizzo Nicholas S.
SmithKline Corporation
LandOfFree
5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-557837